Tetrahexylammonium

Tetrahexylammonium

SCHEMBL635372

CC(=O)[O-].CCCCCC[N+](CCCCCC)(CCCCCC)CCCCCC

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Tetrahexylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 3/20 0.65
ALDH1A1 P00352 1/20 0.62
TP53 P04637 1/20 0.62
CYP3A4 P08684 1/20 0.62
ALOX15 P16050 1/20 0.62
TSHR P16473 1/20 0.62
ALOX12 P18054 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
HIF1A Q16665 1/20 0.62
HSD17B10 Q99714 1/20 0.62
SLC22A2 O15244 1/20 0.60
DNM1 Q05193 4/20 0.56
CES2 O00748 2/20 0.50
CES1 P23141 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL28586661 1.00 SLC22A1 (0.65) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Acetic Acid SCHEMBL27951358 1.00 SLC22A1 (0.65) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Acetic Acid SCHEMBL636396 1.00 SLC22A1 (0.65) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Acetic Acid SCHEMBL5210557 1.00 SLC22A1 (0.65) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Acetic Acid SCHEMBL4329690 1.00 SLC22A1 (0.65) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Acetic Acid SCHEMBL7550200 1.00 SLC22A1 (0.65) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Acetic Acid SCHEMBL30698147 0.98 SLC22A1 (0.62) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Acetic Acid SCHEMBL30698149 0.98 SLC22A1 (0.62) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Acetic Acid SCHEMBL8377274 0.98 SLC22A1 (0.62) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Acetic Acid SCHEMBL27957644 0.98 SLC22A1 (0.62) SLC22A1ALDH1A1TP53CYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114806206-B Modified degradable biomass fiber and preparation method thereof 青岛易旅家居科技有限公司 2022-09-02 CN claimed
CN-114806206-A Modified degradable biomass fiber and preparation method thereof 青岛易旅家居科技有限公司 2022-07-29 CN claimed
EP-3548575-A1 ABRASION RESISTANT COATING COMPOSITION WITH INORGANIC METAL OXIDES Momentive Performance Materials Inc. (US) 2019-10-09 EP claimed
WO-2018102510-A1 ABRASION RESISTANT COATING COMPOSITION WITH INORGANIC METAL OXIDES MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2018-06-07 WO claimed
US-20180148601-A1 ABRASION RESISTANT COATING COMPOSITION WITH INORGANIC METAL OXIDES MOMENTIVE PERFORMANCE MATERIALS INC. 2018-05-31 US claimed
US-8575245-B2 Tunable polymer compositions NOVOMER, INC. (US) 2013-11-05 US claimed
US-20110257296-A1 TUNABLE POLYMER COMPOSITIONS NOVOMER, INC. (US) 2011-10-20 US claimed
WO-2010075232-A1 TUNABLE POLYMER COMPOSITIONS NOVOMER, INC. (US) 2010-07-01 WO claimed
EP-1006374-B1 Process for producing a resin having a large refractive index MITSUBISHI GAS CHEMICAL CO (JP) 2009-01-07 EP claimed
US-4522729-A CXONTACTING IMPORITIES WITH TETRAALKYLAMMONIUM SALT PHILLIPS PETROLEUM COMPANY (US) 1985-06-11 US claimed
EP-3768763-B1 SILICONE POLYMER AND COMPOSITION COMPRISING THE SAME MOMENTIVE PERFORMANCE MAT INC (US) 2026-04-29 EP disclosed
EP-4703126-A1 CELLULOSE MOLDED BODY PRODUCTION METHOD AND CELLULOSE MOLDED BODY Futamura Kagaku Kabushiki Kaisha (JP) 2026-03-04 EP disclosed
US-20260048556-A1 MANUFACTURING METHOD FOR CELLULOSE MOLDED BODY AND CELLULOSE MOLDED BODY FUTAMURA KAGAKU KK (JP) 2026-02-19 US disclosed
EP-4665777-A1 HYDROPHILIC COPOLYMER AND COATING COMPOSITION COMPRISING THE SAME AND ANTIFOG USE THEREOF Momentive Performance Materials Inc. (US) 2025-12-24 EP disclosed
EP-3935114-B1 PROTECTIVE COATING COMPOSITION AND COATED METALLIC SUBSTRATE COMPRISING SAME MOMENTIVE PERFORMANCE MAT INC (US) 2025-07-16 EP disclosed
EP-1006374-A2 Process for producing a resin having a large refractive index MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2000-06-07 EP disclosed
EP-0950905-A2 Process for producing a novel resin for optical materials having excellent color tone and transparency MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1999-10-20 EP disclosed
EP-0936233-A2 Composition for a resin MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1999-08-18 EP disclosed
US-4522729-A CXONTACTING IMPORITIES WITH TETRAALKYLAMMONIUM SALT PHILLIPS PETROLEUM COMPANY (US) 1985-06-11 US disclosed
US-4348431-A DISPERSION OF COLLOIDAL SILICA IN A ALCOHOL-WATER SOLUTION OF A PARTIAL CONDENSATE OF A POLYSILOXANE GENERAL ELECTRIC COMPANY (US) 1982-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260048556-A1 MANUFACTURING METHOD FOR CELLULOSE MOLDED BODY AND CELLULOSE MOLDED BODY AMY1A, MMP1, GYS2 SLC22A1 3111/4885ALDH1A1 1144/4885TP53 3995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.